XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Cash flows from operating activities:    
Net income (loss) $ 53,547 $ (138,442)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 25,633 27,924
Non-cash lease expense 45,422 48,370
Provision (benefit) for deferred income taxes 37 (14,388)
Share-based compensation expense 4,570 4,872
Store impairment   14,528
Loss on disposition of property and equipment, net 121 439
Changes in assets and liabilities:    
Receivables 4,760 32,118
Inventory (87,427) 71,759
Prepaid expenses and other assets (1,355) (50,542)
Payables, accrued expenses and other liabilities 43,442 (29,071)
Operating lease liabilities (51,644) (27,219)
Net cash provided by (used in) operating activities 37,106 (59,652)
Cash flows from investing activities:    
Cash paid for property and equipment (42,589) (43,518)
Cash paid for marketable securities (94,889) (45,517)
Sales and maturities of marketable securities 73,848 311,258
Net cash (used in) provided by investing activities (63,630) 222,223
Cash flows from financing activities:    
Borrowings under debt   220,000
Proceeds from the exercise of stock options 1,073  
Share repurchases related to share repurchase program   (7,036)
Share repurchases related to taxes for share-based awards (7,418) (3,720)
Net cash (used in) provided by financing activities (6,345) 209,244
Effect of exchange rate changes on cash and cash equivalents 1,481 (4,914)
(Decrease) increase in cash and cash equivalents (31,388) 366,901
Cash and cash equivalents at beginning of period 395,635 221,839
Cash and cash equivalents at end of period 364,247 588,740
Cash paid during the year for:    
Income taxes 1,095 6,342
Non-cash investing activities—Accrued capital expenditures $ 40,018 $ 5,176